In February 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
The new test launched in February 2019 by Mayo Clinic Laboratories:
- Thrombospondin Type–1 Domain-Containing 7A Antibodies, Serum (Mayo ID: THSD7)
In addition to these new tests, the department also announced several test changes. Click the links below to view test changes announced via Mayo Clinic Laboratories: